Science News

The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury.

A new interesting article has been published in J Cell Physiol. 2018 Oct 20. doi: 10.1002/jcp.27353. [Epub ahead of print] Review and titled:

The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury.

Authors of this article are:

Mihanfar A, Nejabati HR, Fattahi A, Latifi Z, Pezeshkian M, Afrasiabi A, Safaie N, Jodati AR, Nouri M.

A summary of the article is shown below:

Coronary artery disease (CAD) is a common cause of morbidity and mortality worldwide. Atherosclerotic plaques, as a hallmark of CAD, cause chronic narrowing of coronary arteries over time and could also result in acute myocardial infarction (AMI). The standard treatments for ameliorating AMI are reperfusion strategies, which paradoxically result in ischemic reperfusion (I/R) injury. Sphingosine 1 phosphate (S1P), as a potent lysophospholipid, plays an important role in various organs, including immune and cardiovascular systems. In addition, high-density lipoprotein, as a negative predictor of atherosclerosis and CAD, is a major carrier of S1P in blood circulation. S1P mediates its effects through binding to specific G protein-coupled receptors, and its signaling contributes to a variety of responses, including cardiac inflammation, dysfunction, and I/R injury protection. In this review, we will focus on the role of S1P in CAD and I/R injury as a potential therapeutic target.

Check out the article’s website on Pubmed for more information:



This article is a good source of information and a good way to become familiar with topics such as:

acute myocardial infarction (AMI);coronary artery disease;high-density lipoprotein;ischemia/reperfusion injury;sphingosine

.

Categories: Science News